FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

40 letters match. Newest first.

  1. Chongqing Qiancan Technology Co., Ltd.

    Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.

    High risk
  2. Tianjin Healthcare Medical Technology Co., Ltd.

    Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.

    High risk
  3. Guangdong Bisutang Biotechnology Co., Ltd.

    Guangdong Bisutang Biotechnology refused FDA records requests for OTC drugs and used a cancelled color additive in sunscreen.

    High risk
  4. Yangzhou Hongshengding Chemical Co., Ltd.

    Yangzhou Hongshengding Chemical refused FDA records requests for its over-the-counter drugs, leading to an import alert.

    High risk
  5. Revlon Group Holdings, LLC

    FDA cited Revlon's Oxford, NC over-the-counter drug plant for failing to test talc for asbestos and weak quality oversight.

    High risk
  6. Zydus Lifesciences Limited

    FDA warns Zydus Lifesciences over untested asbestos in talc used in its prescription drugs and altered lab data at its Himachal Pradesh plant.

    High risk
  7. Aeroflex Industria de Aerosol Ltda.

    Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.

    High risk
  8. Hangzhou Yiqi Biotechnology Co., Ltd

    FDA cited Hangzhou Yiqi Biotechnology, an API maker in China, for four manufacturing practice failures found in a records review.

    High risk
  9. Unomedical Device S.A. de C.V.

    FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.

    High risk
  10. Media Networks Sydney Pty. Limited

    FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.

    High risk
  11. Cellebration LLC

    FDA warns Cellebration LLC over unapproved cord-blood cellular products and refusal to provide requested records.

    High risk
  12. Yangzhou Yulou Paper Products Co., Ltd.

    FDA cited Yangzhou Yulou Paper Products for manufacturing violations after records showed its OTC sterile drugs lacked sterility assurance and testing.

    High risk
  13. Sterling Distributors

    FDA warned Florida drug wholesaler Sterling Distributors for shipping prescription drugs without licenses and ignoring a counterfeit report.

    High risk
  14. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk
  15. Zenzi Pharmaceutical Industries Pvt. Ltd.

    Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.

    High risk
  16. Akron Formulations India Private Limited

    Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.

    High risk
  17. Mother Stem Institute, Corp.

    FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.

    High risk
  18. Zen Enterprises LLC

    Zen Enterprises failed to correct drug listing files that named a manufacturer not involved in making its balms and hand sanitizers.

    Low
  19. Wipro Unza Singapore Private, Limited

    FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.

    High risk
  20. Saruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi

    FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.

    High risk
  21. Hygienic Labs, LLC

    Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.

    Medium
  22. Zhao Qing Longda Biotechnology Co. Ltd.

    FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.

    High risk
  23. Gulf States International, Inc.

    Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.

    Medium
  24. Maison Blanche LLC

    FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.

    Medium
  25. Cergomex Imports, LLC

    Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.

    Medium
  26. GTP International Corp

    GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.

    Medium
  27. KM Pharmaceutical Co. Ltd.

    FDA says KM Pharmaceutical refused to provide drug records and placed all its drugs on import alert.

    High risk
  28. Sangleaf Pharm., Co. Ltd.

    Sangleaf Pharm failed to give FDA requested records for OTC drugs, including children's toothpaste, at risk of DEG/EG contamination.

    High risk
  29. Skyline Herbals Private Limited

    FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.

    High risk
  30. Daxal Cosmetics Private Limited

    FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.

    High risk
  31. Chengdu KeCheng Fine Chemicals Co., Ltd.

    FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.

    High risk
  32. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  33. Chemical Services Group, Inc./Royal Chemical Company

    Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.

    High risk
  34. Clean Cosmetics LLC

    FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.

    High risk
  35. The Anthos Group, Inc.

    Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.

    Medium
  36. Guangzhou Orchard Aromatherapy & Skin Care Co., Ltd.

    Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.

    High risk
  37. HealthMEDS Inc.

    HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.

    Medium
  38. True Chemical Solutions, LLC

    FDA cites True Chemical Solutions over unanswered hand sanitizer records requests.

    Medium
  39. Nanomateriales QuĂ­micos Avanzados, S.A. de C.V.

    FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.

    High risk
  40. Furley Bioextracts SDN BHD

    FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.

    High risk